Envoy Medical, Inc. (COCHW) stock
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Envoy Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Envoy Medical's gross margin for the twelve months ending Jun 30, 2026 was -385.5%. For fiscal 2025 it was -262.7%, against -229.8% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -262.7% | −32.9 |
| FY2024 | Dec 31, 2024 | -229.8% | −80.1 |
| FY2023 | Dec 31, 2023 | -149.7% | −39.6 |
| FY2022 | Dec 31, 2022 | -110.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -445.1% | −245.1 |
| Q1 FY2026 | Mar 31, 2026 | -702.6% | −311.3 |
| Q4 FY2025 | Dec 31, 2025 | -181.3% | +92.5 |
| Q3 FY2025 | Sep 30, 2025 | -383.3% | −149.4 |
| Q2 FY2025 | Jun 30, 2025 | -200.0% | +60.3 |
| Q1 FY2025 | Mar 31, 2025 | -391.3% | −232.0 |
| Q4 FY2024 | Dec 31, 2024 | -273.8% | −127.5 |
| Q3 FY2024 | Sep 30, 2024 | -233.9% | −97.7 |
| Q2 FY2024 | Jun 30, 2024 | -260.3% | −103.2 |
| Q1 FY2024 | Mar 31, 2024 | -159.3% | −35.0 |
| Q4 FY2023 | Dec 31, 2023 | -146.3% | +508.7 |
| Q3 FY2023 | Sep 30, 2023 | -136.3% | −50.3 |
| Q2 FY2023 | Jun 30, 2023 | -157.1% | – |
| Q1 FY2023 | Mar 31, 2023 | -124.4% | – |
| Q4 FY2022 | Dec 31, 2022 | -655.0% | – |
| Q3 FY2022 | Sep 30, 2022 | -86.0% | – |